Drug Profile
Research programme: small molecule therapeutics - Rodeo Therapeutics
Latest Information Update: 28 Aug 2021
Price :
$50
*
At a glance
- Originator Rodeo Therapeutics
- Class Anti-inflammatories; Small molecules
- Mechanism of Action Hydroxyprostaglandin dehydrogenase inhibitors; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Bone marrow transplant rejection; Inflammatory bowel diseases; Ulcerative colitis
Most Recent Events
- 28 Aug 2021 No recent reports of development identified for preclinical development in Bone-marrow-transplant-rejection(Prevention) in USA
- 28 Aug 2021 No recent reports of development identified for preclinical development in Inflammatory-bowel-diseases in USA
- 28 Aug 2021 No recent reports of development identified for preclinical development in Ulcerative-colitis in USA